These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Acute reversible renal impairment produced by a uricosuric diuretic. Hubbell FA; Weber MA; Megaffin BB; Brewer DD West J Med; 1980 Nov; 133(5):444-6. PubMed ID: 7467301 [No Abstract] [Full Text] [Related]
27. [Clinically significant interaction between the new diuretic--tienienilic acid and the antithrombotic drugs, derivatives of coumarin]. Prandota J; Panków-Prandota L Przegl Lek; 1982; 39(5):385-8. PubMed ID: 7122922 [No Abstract] [Full Text] [Related]
28. [Acute uratic nephropathy caused by tienilic acid]. Semplicini A; Pessina AC; Palatini P; Casiglia E; Hlede M; Rossi GP G Clin Med; 1981 Jul; 62(7):495-500. PubMed ID: 7308633 [No Abstract] [Full Text] [Related]
29. Acute gout during hypouricaemic therapy: prophylaxis with colchicine. Hollingworth P; Reardon JA; Scott JT Ann Rheum Dis; 1980 Oct; 39(5):529. PubMed ID: 7436588 [No Abstract] [Full Text] [Related]
30. Acute arthralgia (gout?) after tricrynafen. King RS; Wichman BA N Engl J Med; 1979 Nov; 301(19):1065. PubMed ID: 492241 [No Abstract] [Full Text] [Related]
31. [Chronic hepatitis with elevated level of endoplasmic anti-reticulum antibodies: alpha-methyldopa or tienilic acid?]. Beaugrand M; Gavillon C; Ferrier JP Gastroenterol Clin Biol; 1981; 5(8-9):819-20. PubMed ID: 7297821 [No Abstract] [Full Text] [Related]
34. Acute interstitial nephritis in a patient taking tienilic acid. Walker RG; Whitworth JA; Kincaid-Smith P Br Med J; 1980 May; 280(6225):1212. PubMed ID: 7388469 [No Abstract] [Full Text] [Related]
35. [Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. Pariente EA; André C; Zafrani ES; Métreau JM; Dhumeaux D; Berthelot P Gastroenterol Clin Biol; 1981 May; 5(5):567-71. PubMed ID: 7250606 [No Abstract] [Full Text] [Related]
36. [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases]. Lafay JP; Poupon R; Legendre C; Homberg JC; Darnis F Gastroenterol Clin Biol; 1983 May; 7(5):523-8. PubMed ID: 6873565 [No Abstract] [Full Text] [Related]